Peak6 Investments LLC Viking Therapeutics, Inc. Put Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$49.84 - $70.47 $189,392 - $267,786
-3,800 Reduced 50.67%
3,700 $234,000
Q2 2024

Aug 13, 2024
SELL
$47.39 - $80.2 $829,325 - $1.4 Million
-17,500 Reduced 70.0%
7,500 $397,000
Q1 2024

May 14, 2024
BUY
$17.4 - $94.5 $434,999 - $2.36 Million
25,000 New
25,000 $2.05 Million
Q1 2023

May 12, 2023
BUY
$8.08 - $17.33 $202,000 - $433,249
25,000 New
25,000 $416,000

Others Institutions Holding VKTX

# of Institutions
473
Shares Held
66.2M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.95B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email